HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Determinants of the APTT- and ETP-based APC sensitivity tests.

AbstractBACKGROUND:
A reduced sensitivity for activated protein C (APC) is associated with an increased risk of venous thrombosis even in the absence of the factor (F)V Leiden mutation. This risk has been demonstrated with two APC sensitivity tests, which quantify the effects of APC on the activated partial thromboplastin time (APTT) and the endogenous thrombin potential (ETP), respectively.
OBJECTIVES:
We examined determinants of both APC sensitivity tests in the control group of the Leiden Thrombophilia Study (LETS).
METHODS:
Multiple linear regression analysis was performed with normalized APC-SR(APTT) or APC-SR(ETP) as dependent variable and putative determinants [levels of FII, FV, FVII, FVIII, FIX, FX, FXI, FXII, FXIII A subunit, FXIII B subunit, protein S total, protein S free, protein C, tissue factor pathway inhibitor (TFPI) total, TFPI free, antithrombin and fibrinogen] as independent variables.
RESULTS AND CONCLUSIONS:
The major determinant of the APTT-based test was FVIII level, followed by FII level. The ETP-based test was influenced most by free protein S and free TFPI levels. In both tests FXa formation plays a major role, as the effect of FVIII and TFPI on the tests seems to be executed via FXa. The ETP-based test was also strongly influenced by oral contraceptive use, even when we adjusted for all the clotting factors listed above. This means that the effect of oral contraceptives on the ETP-based test is not fully explained by the changes of coagulation factor levels investigated in this study, and that the molecular basis of acquired APC resistance during use of oral contraceptives remains to be established.
AuthorsM C H de Visser, A van Hylckama Vlieg, G Tans, J Rosing, A E A Dahm, P M Sandset, F R Rosendaal, R M Bertina
JournalJournal of thrombosis and haemostasis : JTH (J Thromb Haemost) Vol. 3 Issue 7 Pg. 1488-94 (Jul 2005) ISSN: 1538-7933 [Print] England
PMID15978106 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Anticoagulants
  • Blood Coagulation Factors
  • Coagulants
  • Contraceptives, Oral
  • Lipoproteins
  • Protein C
  • lipoprotein-associated coagulation inhibitor
  • Prothrombin
  • Thrombin
Topics
  • Adolescent
  • Adult
  • Aged
  • Anticoagulants (metabolism)
  • Blood Coagulation Factors (biosynthesis)
  • Blood Coagulation Tests (methods)
  • Coagulants (metabolism, pharmacology)
  • Contraceptives, Oral (pharmacology)
  • Female
  • Genes, APC
  • Humans
  • Lipoproteins (biosynthesis)
  • Male
  • Middle Aged
  • Mutation
  • Partial Thromboplastin Time (methods)
  • Protein C (biosynthesis)
  • Prothrombin (biosynthesis)
  • Risk
  • Sensitivity and Specificity
  • Thrombin (biosynthesis)
  • Thrombophilia (blood, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: